Page last updated: 2024-10-30

losartan and Polyploid

losartan has been researched along with Polyploid in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
"We studied the mechanisms responsible for vascular and cardiac hypertrophy in hypertension (pressure load and humoral and genetic factors) in two experimental approaches: (1) We carried out a cosegregation analysis to correlate cardiac and vascular hypertrophy with subphenotypes of blood pressure in an F2 generation of a cross between stroke-prone spontaneously hypertensive rats (SHRSP) and normotensive Wistar-Kyoto rats; (2) we treated 8-week-old SHRSP with perindopril, an angiotensin-converting enzyme inhibitor; losartan, an angiotensin type 1 receptor antagonist; or perindopril combined with a nitric oxide synthase inhibitor to investigate the relative contributions of blood pressure and angiotensin II to the pathogenesis of cardiac hypertrophy and vascular smooth muscle polyploidy."3.69Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension. ( Anderson, NH; Bohr, DF; Devlin, AM; Dominiczak, AF; Lee, WK; Reid, JL, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dominiczak, AF1
Devlin, AM1
Lee, WK1
Anderson, NH1
Bohr, DF1
Reid, JL1

Other Studies

1 other study available for losartan and Polyploid

ArticleYear
Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:3 Pt 2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl

1996